2 completed, 1 enrolling by invitation, 1 suspended. 4 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 4 | Completed 2, Enrolling by invitation 1, Suspended 1 |
Follow Levodopa: new trials by email Literature Review of Levodopa trials Research Report on Levodopa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sustained Release Oral Formulation for Treatment of Parkinson's Disease levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B - Healthy Volunteers | Early Phase 1 | Completed | University of Minnesota | 6 | 2025-06-12 | 2026-06-25 |
| Treating Early Stage Diabetic Retinopathy Sinemet CR, placebo - Diabetic Retinopathy | Early Phase 1 | Enrolling by invitation | VA Office of Research and Development | 244 | 2022-07-01 | 2026-04-07 |
| Changes in Glutamatergic Neurotransmission of Severe TBI Patients Amantadine + L-DOPA, NMDA blocker - Disorder of Consciousness, Traumatic Brain Injury | Early Phase 1 | Suspended | Weill Medical College of Cornell University | 30 | 2020-09-23 | 2022-09-30 |
| Dopamine and Brain Computer Interface Madopar, Placebo - Healthy Participants | Early Phase 1 | Completed | Max Planck Institute for Human Cognitive and Brain Sciences | 22 | 2017-10-01 | 2025-05-31 |
Brain Injuries, Traumatic (1) · Consciousness Disorders (1) · Diabetes Mellitus (1) · Diabetic Retinopathy (1)
Max Planck Institute for Human Cognitive and Brain Sciences (1) · University of Minnesota (1) · VA Office of Research and Development (1) · Weill Medical College of Cornell University (1)
United States (3) · Germany (1)
Arno Villringer, PhD (1) · Bernhard Sehm, PhD (1) · Esteban A Fridman, MD, PhD (1) · Khalaf Bushara, MD,FRCP (1) · Khosrov A. Grigoryan, MSc (1) · Machelle T. Pardue, PhD (1)